Bayer Co.Lab Joins RESI Boston 2026 as Title Sponsor

September 1, 2026September 3, 2026 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Life Science Nation (LSN) is excited to welcome Bayer Co.Lab as a Title Sponsor of RESI Boston 2026, taking place September 22-23 at the Westin Copley Place in Boston, with virtual partnering continuing September 25 and 28-29.

Bayer Co.Lab is Bayer’s global network of life science incubators supporting early-stage entrepreneurs developing breakthrough technologies. By connecting emerging companies with scientific expertise, mentorship, infrastructure, and Bayer’s broader global network, Co.Lab provides an environment designed to help innovators advance promising science and build the relationships needed for future growth.

Bayer Co.Lab’s mission is closely aligned with RESI’s focus on connecting early-stage life science and healthcare companies with investors, strategic partners, and industry leaders who can accelerate breakthrough therapies.

Bayer Co.Lab’s will be sponsoring a 2-hour session at RESI Boston 2026:

Connecting Asian Biotech Innovation with Global Partners: A Bayer Co.Lab Showcase

Tuesday, September 22, 2:00 – 4:00pm EST

The showcase will bring seven emerging biotechnology companies from Korea and Japan to the RESI stage, highlighting innovative approaches across various therapeutic modalities.

RSVP for Bayer Co.Lab Showcase

artiCure | Korea

Tumor-selective replicating gene therapy targeting solid tumors

Crafton Biotechnology | Japan

mRNA therapeutics supported by advanced computational approaches

Curigin | Korea

RNA-based therapeutic technologies across multiple disease areas

Elisigen | Korea

Next-generation gene therapy with programs in ophthalmology

Genome & Company | Korea

Microbiome-driven therapeutic discovery and development

ILIAS Biologics | Korea

Exosome-based therapeutics for inflammatory and fibrotic diseases

Kanjin Therapeutics | Japan

RNA therapeutics, including siRNA and antisense approaches, for areas of unmet medical need

The program reflects a growing opportunity to connect promising innovation emerging from Asian biotech ecosystems with global pharmaceutical partners, investors, and other strategic collaborators. By bringing Korean and Japanese companies directly into the RESI community, the showcase will create a forum for companies to present their science, build international relationships, and explore pathways for global development and partnership.

Meet Bayer at RESI Boston

Bayer will have a strong presence at RESI Boston, with senior representatives spanning Co.Lab and BD & Licensing departments.

Alberto Nobili Sr. Director, Strategy and Portfolio at Co.Lab	Nobuhiro Kazama Head of Collaborate to Cure Japan Hub	Ilona Gutcher Senior Director, BD&L Oncology
Carla Klattenhoff Senior Director / Scientific US Lead for Research and Early Development in CV, Renal and Immunology	Shivaranjani Sridharan Executive Director, Business Development & Licensing

Their participation gives RESI attendees an opportunity to engage with Bayer leaders representing multiple areas of scientific and strategic interest and to gain greater insight into how a global pharmaceutical company approaches external innovation and collaboration.

Bringing Global Innovators Together in Boston

RESI has always been built around a simple idea: great science can come from anywhere, but moving it forward requires the right connections.

Bayer Co.Lab’s participation as Title Sponsor of RESI Boston 2026 reinforces that mission. From supporting emerging entrepreneurs to creating new connections between Asian biotech innovators and the global life science ecosystem, the collaboration will bring another important dimension to this year’s RESI Boston.

Join Bayer Co.Lab and the global early-stage life science community at RESI Boston 2026!

Building the Innovation Bridge Between Japan and the World

August 25, 2026August 25, 2026 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Japan has world-class science, deep pharmaceutical expertise, and a rich pipeline of emerging life science technology. It is now delivering an innovation bridge that connects that innovation to the global life science community.

At RESI Boston 2026, our 8th annual Global Family Office BioForum Luncheon will bring together international family offices for a private, invitation-only conversation about the emerging bridge between Japan and the rest of the world. I will be joined by Keiko Kobayashi of the Kobe Biomedical Innovation Cluster (KBIC) and Rick Berenson, Managing Director of Venzyme Catalyst.

KBIC is one of Japan’s largest life science clusters, and our work together is centered on three objectives: helping Japanese technology assets enter the global arena, bringing international investors and strategic partners closer to Japan’s innovation ecosystem, and fostering cross-border investment syndicates that connect Japanese and international investors around opportunities in both markets.

The pieces are coming together. KBIC brings the Japanese ecosystem, company pipeline, and government relationships. Venzyme Catalyst brings early-stage assessment, shaping, and de-risking. LSN brings commercialization preparation, RESI, BD Assist, and its global network of investors and licensing partners. Keiko will share what KBIC is building in Japan, while Rick and I will explain how the commercialization engine connects regional innovation to the global marketplace.

Then we will do what has made the BioForum work for eight years: get out of the way and let the room work. The real value is the conversation among family offices as they compare perspectives, share experiences, and build relationships with peers. Attendance is limited and by invitation only. Family offices interested in attending can reply to this newsletter or contact Life Science Nation to request an invitation.

Global Family Office BioForum Luncheon
Tuesday, September 22, 2026, 12:00 to 1:00 pm
Westin Copley Place, Boston
Private and invitation only

RSVP for GFOB Here

Featuring:

Dennis Ford

Founder of Life Science Nation, Creator of RESI, and Architect of LSN Labs

Rick Berenson

Managing Director, Venzyme Catalyst

Keiko Kobayashi

Business Strategies, Head of International Ecosystem Development, KBIC

More Investors. More Opportunities. More Momentum.

August 11, 2026August 11, 2026 ~ Next Phase Admin ~ Leave a comment

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Investor interest in RESI Boston is building quickly as the launch of the RESI partnering platform approaches on Monday, August 17. With partnering just days away, investor registrations are expected to accelerate further as firms prepare to identify companies and begin scheduling one-on-one meetings.

In five days of investor registration, more than 30 investor firms signed up to participate, reinforcing RESI’s position as one of the premier partnering events for early-stage life science companies seeking capital and strategic partnerships.

Recently Confirmed Investors (Last 5 Days)

Explore the full RESI Boston investor list here.

These new registrations join a growing community of investors from across venture capital, corporate venture, family offices, angel groups, foundations, and strategic investment organizations, creating even more opportunities for meaningful one-on-one meetings.

🏷️ Save $300 on RESI Boston Registration

Secure your pass before Early Bird rates end this Friday, August 14th to get full access to investor partnering!

Already, more than 200 investors representing over 150 global investor firms have registered for RESI Boston, with additional investors continuing to join each week.

As the investor roster continues to grow, so do the opportunities to connect with the partners who can help move your company forward.

Register now to join one of the industry’s most active life science partnering events. Early Bird pricing ends Friday, August 14, giving attendees one last opportunity to save $300 before standard rates take effect.

Partnering Launches August 17 for RESI Boston September 2026

August 11, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

RESI Boston September 2026 brings together one of the largest gatherings of early-stage life science investors, pharmaceutical and medtech business development professionals, strategic partners, and innovators during Biotech Week Boston. With two days of in-person networking, educational panels, company presentations, the Innovator’s Pitch Challenge, an active exhibit hall, and dedicated one-on-one partnering, RESI is designed to help emerging life science companies build the relationships that drive fundraising, licensing, strategic partnerships, and commercialization.

One of the event’s most valuable features launches Monday, August 17: the RESI partnering platform.

Beginning August 17, registered attendees can start scheduling one-on-one meetings with investors, pharmaceutical business development teams, strategic partners, and service providers well in advance of the conference.

The RESI series continues to be one of the world’s largest early-stage life science partnering events, bringing together hundreds of active investors and strategic partners focused on biotechnology, AI, medical devices, diagnostics, digital health, and life science tools. Whether attending in person or virtually, participants can use Life Science Nation’s (LSN) proprietary partnering platform to identify organizations that align with their technology, stage of development, therapeutic focus, and fundraising objectives.

Launching your partnering outreach early is one of the best ways to maximize your RESI experience. Companies that complete their profiles and begin requesting meetings as soon as partnering opens gain greater visibility and have more opportunities to secure valuable conversations before schedules begin to fill.

To help attendees make the most of the partnering platform, Life Science Nation will host a complimentary RESI Boston Partnering Tutorial webinar on Tuesday, August 18, at 9:00 AM MT. During this interactive session, LSN staff will demonstrate how to:

Build a compelling partnering profile
Identify investors and strategic partners that best fit your company
Develop an outreach strategy that increases meeting acceptance
Manage meeting requests and follow up effectively
Leverage the partnering platform and conference resources to maximize your RESI experience

🎓 Free Webinar: RESI Partnering Tutorial

Learn outreach strategies to maximize your 1-on-1 investor meetings. Tuesday, Aug 18 @ 11:00 AM ET

Whether you are attending RESI for the first time or are a returning participant, this tutorial offers practical strategies to help you secure more meaningful meetings and maximize your return on investment.

Register now to secure your $300 Early Bird savings before August 14, complete your partnering profile, begin requesting meetings when the platform opens on August 17, and join the complimentary Partnering Tutorial on August 18 to position your company for a productive and successful RESI Boston September 2026.

🏷️ Save $300 on RESI Boston Registration

Secure your pass before Early Bird rates end this Friday, August 14th to get full access to investor partnering!

Establish Your Innovation Hub at RESI JPM 2027

August 4, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

Every January, JPM Healthcare Week transforms San Francisco into the global center of the life science industry, bringing together investors, pharmaceutical executives, biotech leaders, and innovators from around the world. For organizations looking to showcase their regional ecosystem, portfolio companies, or innovation network, RESI JPM 2027 offers a unique opportunity to establish a visible and strategic presence during one of the industry’s most influential weeks.

Located within the San Francisco Marriott Marquis, RESI JPM is the premier partnering conference dedicated to early-stage life science companies. The event connects startups with active investors, strategic partners, and business development professionals through curated partnering meetings, educational programming, and networking opportunities.

Life Science Nation invites regional organizations, innovation hubs, accelerators, and industry partners to create their own branded Innovation Hub alongside RESI JPM. These flexible hosting opportunities allow organizations to provide a central gathering place for their ecosystem while taking advantage of the high concentration of attendees already participating in RESI and JPM Healthcare Week.

RESI JPM 2027 Venue: Salons 9–15 (Yerba Buena Ballroom, Lower B2 Level) with total space exceeding 17,000 sq ft.

Organizations can kick off the week with a private networking reception on Sunday, welcoming investors, founders, corporate partners, and key stakeholders before the week’s meetings begin. During RESI JPM on Monday and Tuesday, dedicated salon spaces adjacent to the conference offer an ideal location for hosting meetings, showcasing portfolio companies, conducting presentations, and serving as a home base for delegates throughout the event.

Tech/Innovation hubs also benefit from prominent branding within the RESI environment and the opportunity for their startup cohorts to engage directly in RESI’s partnering platform, creating additional exposure and meeting opportunities with investors and strategic partners.

Whether representing a regional life science cluster, government agency, incubator, accelerator, or investment organization, establishing an Innovation Hub at RESI JPM positions your organization at the center of the world’s largest life science partnering week while providing lasting value for your innovation ecosystem.

To learn more about creating an Innovation Hub at RESI JPM 2027, contact Life Science Nation at salescore@lifesciencenation.com.

Build an Investor-Ready Company with Life Science Nation’s Education Program

August 4, 2026August 4, 2026 ~ Next Phase Admin ~ Leave a comment

By Karen Deyo, VP of Product, Israel BD, LSN

Raising capital is more than having innovative science. Early-stage life science companies also need a compelling story, a clear fundraising strategy, and the ability to engage the right investors. Life Science Nation’s (LSN) Education Program helps founders build those skills, preparing them for a successful fundraising campaign that typically spans 9 to 18 months.

Designed for biotechnology, medical device, diagnostics, digital health, and life science tool companies, the program gives entrepreneurs practical guidance while helping accelerators, incubators, universities, and regional innovation organizations better prepare their portfolio companies for investor engagement.

Two Programs, One Goal
Organizations can choose the level of support that best fits their companies’ needs.

Preparing and Executing a RESI Event includes:

Three virtual education sessions
In-person Pitch Practice and Shark Tank before RESI

Preparing and Executing a Global Roadshow includes:

Twelve virtual education sessions
A dedicated LSN mentor with coaching between classes
In-person Pitch Practice and Shark Tank

Throughout the curriculum, founders learn how investors evaluate opportunities, refine their branding and messaging, align fundraising goals with company milestones, and develop a systematic approach to investor outreach. Participants also learn how to navigate the RESI Partnering Platform, identify the right investors, execute productive meetings, and build an effective follow-up strategy after the conference.

The program concludes with an in-person Pitch Practice and Shark Tank held before RESI, giving companies the opportunity to present their technology, receive live feedback, and strengthen their investor presentations before meeting with active investors.

Putting Preparation into Practice

The Education Program is designed to prepare companies for the Redefining Early Stage Investments (RESI) Conference Series, where startups connect with active investors, pharmaceutical companies, strategic partners, and service providers from across the global life science ecosystem.

Companies can further increase their visibility by participating in the Innovator’s Pitch Challenge (IPC). Each company delivers a six-minute presentation followed by seven minutes of investor Q&A, while also showcasing its technology in the RESI Exhibition Hall. IPC participants receive additional exposure through the LSN Newsletter and RESI Program Guide, with audience voting determining the competition winners.

Together, the Education Program, RESI Conference, and Innovator’s Pitch Challenge provide founders with a complete framework for fundraising success—from developing an investor-ready message to building meaningful relationships that can help move their companies forward.

Interested in bringing the Life Science Nation Education Program to your portfolio companies? Visit www.lifesciencenation.com and www.resiconference.com to learn more.

Gearing Up for RESI Boston: Master Your Fundraising & Development Strategy at the Pre-RESI Biotech Forum

July 28, 2026 ~ Next Phase Admin ~ Leave a comment

By Max Braht, VP of Business Development, LSN

On Monday, September 21, 2026, the day before RESI Boston 2026, Life Science Nation (LSN) and RESI Boston Silver Sponsor, Certara, will host a Biotech Forum focused on Developing Investor Ready Strategies.

Designed for early-stage biotech companies, the workshop will help founders evaluate their company’s readiness for a global fundraising campaign by identifying opportunities to strengthen their development strategy and reduce key scientific, clinical, regulatory, commercial, and fundraising risks. Through expert-led sessions and interactive discussions, attendees will gain practical insights into what investors look for during diligence, how to build a credible development roadmap, and how to position their company for successful fundraising.

Held immediately before RESI Boston, the workshop gives companies the opportunity to refine their strategy and messaging before meeting with investors and strategic partners throughout RESI.

Not yet signed up for RESI Boston 2026: Register Here

We look forward to welcoming you to the CIC in Cambridge as we kick off RESI Boston 2026 with a day dedicated to helping innovative biotech companies become truly investor ready.